Modelling the cost effectiveness of TNF-α antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

A. Brennan; N. Bansback; R. Nixon; J. Madan; M. Harrison; K. Watson; and D. Symmons

首页> 外文期刊>Rheumatology >Modelling the cost effectiveness of TNF-α antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

【24h】

Modelling the cost effectiveness of TNF-α antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

机译：模拟风湿性关节炎治疗中TNF-α拮抗剂的成本效益：英国风湿病生物学学会注册处的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objective. To evaluate the cost effectiveness of TNF-α antagonist therapies for rheumatoid arthritis (RA) in the United Kingdom using data from the British Society for Rheumatology Biologics Registry (BSRBR).

机译：目的。若要评估风湿性关节炎（RA）在英国的TNF-α拮抗剂疗法的成本效益，使用英国风湿病生物学学会注册机构（BSRBR）的数据。

著录项

来源
《Rheumatology》 |2007年第8期|1345-1354|共10页
作者
A. Brennan; N. Bansback; R. Nixon; J. Madan; M. Harrison; K. Watson; and D. Symmons;
展开▼
作者单位

Health Economics and Decision Science School of Health and Related Research (ScHARR) The University of Sheffield UK;

Centre for Health Evaluation and Outcome Sciences St Paul's Hospital Vancouver BC Canada;

MRC Biostatistics Unit Institute of Public Health University Forvie Site Robinson Way Cambridge CB2 2SR and;

Arthritis Research Campaign Epidemiology Unit The University of Manchester Medical School Manchester M13 9PT UK.;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Comment on: Modelling the cost effectiveness of TNF-α antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry: reply [J] . N. Bansback1 A. Brennan2 D. Symmons3 R. Nixon4 J. Madan2 M. Harrison3 and K. Watson3 Rheumatology . 2008,第7期

机译：评论：在类风湿关节炎的治疗中模拟TNF-α拮抗剂的成本效益：英国风湿病生物学学会注册处的结果：答复
2. Comment on: Modelling the cost effectiveness of TNF antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry [J] . R. F. van Vollenhoven Rheumatology . 2008,第7期

机译：评论：在类风湿关节炎的治疗中模拟TNF拮抗剂的成本效益：英国风湿病生物学学会注册处的结果
3. Comment on: Modelling the cost effectiveness of TNF antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry. [J] . van-Vollenhoven RF Rheumatology . 2008,第7期

机译：评论：在类风湿性关节炎的治疗中模拟TNF拮抗剂的成本效益：英国风湿病生物学学会注册处的结果。
4. Low molecular weight CXCR4 antagonists based on T140 analogs that were identified as triple-functional agents having inhibitory activities against HIV infection,cancer metastasis and rheumatoid arthritis [C] . Hirokazu Tamamura, Kenichi Hiramatsu, Takanobu Araki International Peptide Symposium;European Peptide Symposium . 2005

机译：基于T140类似物的低分子量CXCR4拮抗剂，其被鉴定为具有针对HIV感染，癌症转移和类风湿性关节炎的抑制活性的三官能药物
5. Models and outcomes of team care for the management of rheumatoid arthritis across different countries: A systematic review. [D] . Chhabra, Monika. 2009

机译：跨国治疗类风湿关节炎的团队护理模型和结果：系统评价。
6. Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis [O] . Mari Kihara, Rebecca Davies, Lianne Kearsley-Fleet, -1

机译：类风湿关节炎患者中托西珠单抗的使用和效果：英国风湿病生物学学会对类风湿关节炎的观察研究
7. Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry [O] . A. Brennan, N. Bansback, R. Nixon, 2015

机译：模拟TNF-拮抗剂治疗类风湿性关节炎的成本效益：来自英国风湿病学会生物制剂登记处的结果

Modelling the cost effectiveness of TNF-α antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅